Evangeline Thibodeau
Infectious Disease · York, MENPI 1205005444
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $151 of the $191 with a category attached, or 79.1%. It is spread thinly across 9 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $116 and has fallen 50.1% since, to $58 in 2023.
Across 10 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$40
- Merck$25
- AbbVie$24
- Aimmune Therapeutics, Inc.$18
- Tetraphase Pharmaceuticals, Inc.$18
- Organogenesis Inc.$18
- plus $49 from 3 others
What the payments were for
- Food & beverage$15179%
- Education$4021%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 1 | $40 |
| Merck | 2 | $25 |
| AbbVie | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $18 |
| Viiv Healthcare Company | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Smith+Nephew | 1 | $16 |
How this compares
$191 in reported general payments places this provider in the 65th percentile of 29 infectious disease providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TriumeqAbacavir/Dolutegravir/Lamivudi | 21 | $83,241 |
| PrezcobixDarunavir/Cobicistat | 26 | $80,480 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 16 | $63,921 |
| JulucaDolutegravir/Rilpivirine | 12 | $41,420 |
| DescovyEmtricitabine/Tenofov Alafenam | 12 | $26,569 |
| Fosfomycin Tromethamine | 15 | $5,361 |
| Methenamine Hippurate | 53 | $4,073 |
| Meropenem | 11 | $1,867 |
| Atovaquone-Proguanil HclAtovaquone/Proguanil Hcl | 21 | $1,667 |
| Doxycycline Hyclate | 24 | $1,138 |
| Rifampin | 16 | $1,062 |
| Cefepime Hcl | 15 | $882 |
| Cephalexin | 51 | $671 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $539 |
| CeftriaxoneCeftriaxone Sodium | 21 | $433 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyTriumeq, Juluca | $17 | $124,66133 claims |
| Johnson & JohnsonPrezcobix | $16 | $80,48026 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 29 infectious disease providers in Maine.
Other infectious disease in York
- Gretchen VolpeYork$33
- Christina YenPortland$10K
- Daniel DiekemaSouth Portland$2K
- Vinod MohanBangor$2K
- Patricia StogsdillSouth Portland$740
- Rebekah GassBangor$528
- Matthew CarrollBath$501
- Timothy BorelliAugusta$420
- Jenae LimogesLewiston$380
- Thomas CourtneyBiddeford$283
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.